‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access
The peptide market is experiencing significant growth, driven by the popularity of GLP-1 weight-loss medications. The FDA is considering easing regulations on various peptides, which are often sold through compounding pharmacies and unverified vendors. Experts warn that while peptides can be beneficial, consumers should approach them cautiously and consult with healthcare professionals.
- ▪Peptides are short chains of amino acids that play key roles in biological functions.
- ▪The FDA is set to evaluate regulations on several peptides during a meeting this summer.
- ▪Demand for peptides is strong, potentially challenging pharmaceutical companies that dominate the GLP-1 market.
Opening excerpt (first ~120 words) tap to expand
Health ‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access Compounding pharmacies invested millions during national GLP-1 shortage and now face pushback from drugmakers By Angelica Stabile Fox News Published May 21, 2026 7:00am EDT Facebook Twitter Threads Flipboard Comments Print Email Add Fox News on Google close Video Peptides can be useful, but some people may be moving too fast, expert warns New York fitness trainer and gym owner Kenny Santucci discusses concerns about unverified peptide products for muscle building, saying consumers should work with physicians. NEWYou can now listen to Fox News articles! As GLP-1 weight-loss medications gain traction, the peptide market is experiencing a surge in interest.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fox News.
Discussion
0 commentsMore from Fox News
